Home | Welcome to Contract Pharma   
Last Updated Saturday, May 23 2015


Impax Laboratories Names CFO

Published December 13, 2012
Bryan M. Reasons has been appointed senior vice president and chief financial officer at Impax Laboratories. Mr. Reasons joined the company in January 2012 as vice president of finance and has served as acting CFO since June 2012.
Prior to joining the company, Mr. Reasons served as vice president of finance, as well as vice president of risk management and general auditor, at Cephalon, Inc. Following the acquisition of Cephalon by Teva, he served briefly as the vice president of finance at Teva.
“Following a nationwide search, Bryan Reasons was selected as the best candidate to fill the CFO role,” said Larry Hsu, Ph.D., president and chief executive officer, Impax Laboratories. “He has a breadth of knowledge across accounting and finance, combined with extensive merger and acquisition experience within the pharmaceutical industry. In less than two years, we have significantly transformed Impax’s leadership team across a number of functions as we focus on executing our growth strategy.”

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On